Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study
Authors:
- Kevin P Mc NamaraKNKevin P Mc Namara
- Johnson GeorgeJGJohnson George
- Sharleen L O'REillySOSharleen L O'REilly
- Shane L JacksonSJShane L Jackson
- Gregory M PetersonGregory M Peterson
- Helen HowarthHHHelen Howarth
- Michael J BaileyMBMichael J Bailey
- Gregory DuncanGDGregory Duncan
- Peta TrinderPTPeta Trinder
- Elizabeth MorabitoEMElizabeth Morabito
- Jill FinchJFJill Finch
- Stephen BunkerSBStephen Bunker
Open Access
- 7 September 2010
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 10 (1) , 264
Abstract
Cardiovascular disease (CVD) is the leading cause of death globally. Community pharmacist intervention studies have demonstrated clinical effectiveness for improving several leading individual CVD risk factors. Primary prevention strategies increasingly emphasise the need for consideration of overall cardiovascular risk and concurrent management of multiple risk factors. It is therefore important to demonstrate the feasibility of multiple risk factor management by community pharmacists to ensure continued currency of their role. This study will be a longitudinal pre- and post-test pilot study with a single cohort of up to 100 patients in ten pharmacies. Patients aged 50-74 years with no history of heart disease or diabetes, and taking antihypertensive or lipid-lowering medicines, will be approached for participation. Assessment of cardiovascular risk, medicines use and health behaviours will be undertaken by a research assistant at baseline and following the intervention (6 months). Validated interview scales will be used where available. Baseline data will be used by accredited medicines management pharmacists to generate a report for the treating community pharmacist. This report will highlight individual patients' overall CVD risk and individual risk factors, as well as identifying modifiable health behaviours for risk improvement and suggesting treatment and behavioural goals. The treating community pharmacist will use this information to finalise and implement a treatment plan in conjunction with the patient and their doctor. Community pharmacists will facilitate patient improvements in lifestyle, medicines adherence, and medicines management over the course of five counselling sessions with monthly intervals. The primary outcome will be the change to average overall cardiovascular risk, assessed using the Framingham risk equation. This study will assess the feasibility of implementing holistic primary CVD prevention programs into community pharmacy, one of the most accessible health services in most developed countries. Australia and New Zealand Clinical Trial Registry Number: ACTRN12609000677202Keywords
This publication has 27 references indexed in Scilit:
- Vascular risk checks in the UK: strategic challenges for implementationHeart, 2009
- Modeling Health Behavior Change: How to Predict and Modify the Adoption and Maintenance of Health BehaviorsApplied Psychology, 2008
- Prevention of Type 2 Diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention ProjectBMC Public Health, 2007
- The economics of primary prevention of cardiovascular disease – a systematic review of economic evaluationsCost Effectiveness and Resource Allocation, 2007
- Development and validation of the Beliefs and Behaviour Questionnaire (BBQ)Patient Education and Counseling, 2006
- Do Trends in Population Levels of Blood Pressure and Other Cardiovascular Risk Factors Explain Trends in Stroke Event Rates?Stroke, 2002
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- The world health organization monica project (monitoring trends and determinants in cardiovascular disease): A major international collaborationJournal of Clinical Epidemiology, 1988
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986
- The CES-D ScaleApplied Psychological Measurement, 1977